231 related articles for article (PubMed ID: 37745707)
1. The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data.
Si Y; Fei Y; Ma H; Xu Y; Ning L; Li X; Ren Q
Front Endocrinol (Lausanne); 2023; 14():1229900. PubMed ID: 37745707
[TBL] [Abstract][Full Text] [Related]
2. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
3. Causal associations between thyroid dysfunction and COVID-19 susceptibility and severity: A bidirectional Mendelian randomization study.
Zhang Z; Fang T; Lv Y
Front Endocrinol (Lausanne); 2022; 13():961717. PubMed ID: 36147565
[TBL] [Abstract][Full Text] [Related]
4. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
5. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.
Zhao Y; Xu Y; Wang X; Xu L; Chen J; Gao C; Wu C; Pan D; Zhang Q; Zhou J; Chen R; Wang Z; Zhao H; You L; Cao Y; Li Z; Shi Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32163573
[TBL] [Abstract][Full Text] [Related]
6. Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.
Zhu T; Goodarzi MO
J Clin Endocrinol Metab; 2022 Feb; 107(3):e899-e911. PubMed ID: 34669940
[TBL] [Abstract][Full Text] [Related]
7. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional Mendelian randomization study.
Wang J; Fiori PL; Capobianco G; Carru C; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1275419. PubMed ID: 38318294
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
Li GH; Tang CM; Cheung CL
Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
[No Abstract] [Full Text] [Related]
11. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
[TBL] [Abstract][Full Text] [Related]
12. Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.
Chen S; Guo Z; Yu Q
Hum Genomics; 2023 Nov; 17(1):100. PubMed ID: 37957681
[TBL] [Abstract][Full Text] [Related]
13. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study.
Ma Y; Cai J; Liu LW; Hou W; Wei Z; Wang Y; Xu Y
Int J Gynaecol Obstet; 2023 Sep; 162(3):1050-1056. PubMed ID: 37128830
[TBL] [Abstract][Full Text] [Related]
14. Mendelian randomization reveals no causal relationship between COVID-19 susceptibility, hospitalization, or severity and epilepsy.
He Z; Li Y; Liu S; Li J
Epilepsia Open; 2023 Dec; 8(4):1452-1459. PubMed ID: 37602490
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic and genetic associations of female reproductive disorders with depression or dysthymia: a Mendelian randomization study.
Ling S; Dai Y; Weng R; Li Y; Wu W; Zhou Z; Zhong Z; Zheng Y
Sci Rep; 2024 Mar; 14(1):5984. PubMed ID: 38472314
[TBL] [Abstract][Full Text] [Related]
16. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
Yoshikawa M; Asaba K; Nakayama T
BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
[TBL] [Abstract][Full Text] [Related]
17. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
[TBL] [Abstract][Full Text] [Related]
18. Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and Mendelian randomization study.
Sun J; Wang M; Kan Z
Front Endocrinol (Lausanne); 2024; 15():1280983. PubMed ID: 38362275
[TBL] [Abstract][Full Text] [Related]
19. Maternal Polycystic Ovary Syndrome and Offspring Birth Weight: A Mendelian Randomization Study.
Gan Y; Lu D; Yan C; Zhang J; Zhao J
J Clin Endocrinol Metab; 2022 Mar; 107(4):1020-1029. PubMed ID: 34849988
[TBL] [Abstract][Full Text] [Related]
20. Association between COVID-19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study.
Sun D; Tu L; Wang X; Du Q; Wang R; Shi Z; Chen H; Zhou H
Brain Behav; 2023 Nov; 13(11):e3239. PubMed ID: 37638499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
